Clinical Trial

Virtual Reality-Based 'Health at My Feet' Program for Individuals With Type 2 Diabetes

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled experimental study aims to develop and evaluate the effectiveness of a Virtual Reality-Based "Health to My Foot" program designed for individuals with Type II Diabetes Mellitus. The study will assess the program's impact on diabetic foot knowledge, foot care self-efficacy, foot care behaviors, and foot health outcomes. The research will be conducted between April and October 2026 at a university hospital diabetes outpatient clinic in İzmir, Türkiye. A total of 70 participants diagnosed with Type II DM will be enrolled and randomly assigned to either the intervention group (n=35) or the control group (n=35) using stratified block randomization. Participants in the intervention group will receive the Virtual Reality-Based "Health to My Foot" program through virtual reality goggles and will have access to a recorded foot care training video for home use. They will also receive weekly motivational reminder messages for three months. The control group will receive standard outpatient care only. Data will be collected at baseline (pre-test), 1 month (post-test), and 3 months (follow-up) using validated scales and a nurse follow-up form to evaluate knowledge, self-efficacy, behaviors, and clinical foot health indicators. The findings are expected to contribute to sustainable patient education strategies and to support the prevention of diabetic foot complications and reduction of healthcare costs.
Trial Details
NCT Number NCT07473050
Lead Sponsor Ege University
Conditions Diabetic Foot - Telemedical Monitoring, Diabetic, Foot Care, Virtual Reality
Enrollment 70 participants
Start Date 2026-04-16
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-16